Drug News
-
FDA Approves First Medication to Help Reduce Allergic Reactions to Multiple Foods After Accidental Exposure
In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has granted approval for the use of Xolair (Omalizumab)…
Read More » -
US FDA Grants Accelerated Approval for Iovance’s Skin Cancer Cell Therapy
Iovance Biotherapeutics announced on Friday that the U.S. health regulator has granted accelerated approval for its cell therapy aimed at…
Read More » -
Hard Hit by the US Opioid Crisis, Oregon Reconsiders The Decriminalization Option
As the United States grapples with an escalating opioid crisis, the state of Oregon finds itself at a crossroads regarding…
Read More » -
Exclusive Data Reveals Wegovy Fueling Sharp Rise In Use Of Weight-Loss Drugs For U.S. Youth
The usage of Novo Nordisk’s weight-loss drug Wegovy among adolescents in the United States has shown a significant increase, according…
Read More » -
Pfizer Agrees To Pay $93 Million For Lipitor Antitrust Lawsuit Settlement
Pfizer, a renowned pharmaceutical company, has reached an agreement to pay a substantial sum of $93 million to settle antitrust…
Read More » -
Pharmaceutical Group’s Lawsuit On Medicare Drug Price Program Dismissed
A federal judge in Austin, Texas, has dismissed a lawsuit filed by the Pharmaceutical Research and Manufacturers of America (PhRMA)…
Read More » -
Global IV & Oral Iron Drugs Market Report 2024: Market to Reach $16.43 Billion by 2029
Research and Markets has released a report titled “Global IV & Oral Iron Drugs Market – Focused Insights 2024-2029” offering…
Read More » -
Antithrombotic/Anticoagulant Drugs Market Forecasted to Surge to $46.2 Billion by 2028
BCC Research LLC, a leading provider of market intelligence, unveils an optimistic forecast for the Antithrombotic/Anticoagulant Drugs market, estimating its…
Read More » -
Ozempic Maker Settles With Florida Spa, Clinic Over Cheaper Compounded Versions
Novo Nordisk, a major player in the pharmaceutical industry, recently reached settlements in lawsuits against two defendants: Cosmetic Laser Professionals…
Read More » -
Novo Nordisk’s Controlling Shareholder Plans To Invest About $7 Billion a Year By 2030
Novo Holdings, the controlling shareholder of Novo Nordisk, a prominent Danish pharmaceutical company known for its focus on obesity and…
Read More »